GB2029220B - Amino acid solutions for patients with cancers - Google Patents
Amino acid solutions for patients with cancersInfo
- Publication number
- GB2029220B GB2029220B GB7929789A GB7929789A GB2029220B GB 2029220 B GB2029220 B GB 2029220B GB 7929789 A GB7929789 A GB 7929789A GB 7929789 A GB7929789 A GB 7929789A GB 2029220 B GB2029220 B GB 2029220B
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancers
- patients
- amino acid
- acid solutions
- solutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10874978A JPS5535049A (en) | 1978-09-04 | 1978-09-04 | Amino acid transfusion for cancerous patient |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2029220A GB2029220A (en) | 1980-03-19 |
GB2029220B true GB2029220B (en) | 1983-03-30 |
Family
ID=14492527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7929789A Expired GB2029220B (en) | 1978-09-04 | 1979-08-28 | Amino acid solutions for patients with cancers |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5535049A (en) |
AU (1) | AU526207B2 (en) |
CA (1) | CA1134275A (en) |
CH (1) | CH642541A5 (en) |
DE (1) | DE2935709C2 (en) |
FR (1) | FR2434622A1 (en) |
GB (1) | GB2029220B (en) |
IT (1) | IT1194844B (en) |
NL (1) | NL190266C (en) |
SE (1) | SE448679B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10201513B2 (en) | 2016-12-19 | 2019-02-12 | Axcella Health Inc. | Amino acid compositions and methods for the treatment of liver diseases |
US10596136B2 (en) | 2018-06-20 | 2020-03-24 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
US10660870B2 (en) | 2017-08-14 | 2020-05-26 | Axcella Health Inc. | Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58500526A (en) * | 1981-04-17 | 1983-04-07 | アメリカン ホスピタル サプライ コ−ポレ−シヨン | Improved solutions for parenteral nutrition |
FR2508797B1 (en) * | 1981-07-03 | 1986-03-14 | Charles Chany | MEDICINAL PRODUCT COMPRISING THE REACTION OF A C1 TO C6 CARBOXYLIC ACID ON A BASIC AMINO ACID |
DE3329253A1 (en) * | 1983-08-12 | 1985-02-21 | Milupa Ag, 6382 Friedrichsdorf | Use of an amino acid mixture for the control of, in particular, lymphadenomas |
HU191598B (en) * | 1984-03-20 | 1987-03-30 | Egyt Gyogyszervegyeszeti Gyar | Method for the preparation of injection solution suitable preferably against cathosis |
DE3440090A1 (en) * | 1984-11-02 | 1986-05-07 | Novo-Med AG, Appenzell | MEDICINAL SOLUTION CONTAINING AMINOSAUR SOLUTIONS FOR THE TREATMENT OF CANCER DISEASES AND METHOD FOR THE PRODUCTION THEREOF |
IL77629A (en) * | 1985-01-22 | 1989-07-31 | Abbott Lab | High fat,low carbohydrate enteral nutritional for mula |
FR2591893B1 (en) * | 1985-12-19 | 1988-11-10 | Centre Nat Rech Scient | METHIONINE-DEFECTED NUTRITIONAL COMPOSITIONS FOR INHIBITING THE DEVELOPMENT AND DISSEMINATION OF MALIGNANT TUMORS IN MAMMALS |
US5162373A (en) * | 1986-01-17 | 1992-11-10 | Board Of Regents, The University Of Texas System | Methods and improved formulations for the determination and treatment of malignant disease in patients |
US5189025A (en) * | 1988-12-09 | 1993-02-23 | Board Of Regenets, The University Of Texas System | Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions |
GB8917660D0 (en) * | 1989-08-02 | 1989-09-20 | Rana Ashok S J | Prophylaxis of transurethral resection reactions |
US5658895A (en) * | 1991-10-07 | 1997-08-19 | Otsuka Pharmaceutical Factory, Inc. | Anticancer enteral feeding composition |
ATE183923T1 (en) * | 1991-10-07 | 1999-09-15 | Otsuka Pharma Co Ltd | ENTERAL PREPARATIONS FOR CANCER THERAPY |
DE4228897A1 (en) * | 1992-08-29 | 1994-03-03 | Wella Ag | Hair setting agent based on lignin or lignin derivatives and dihydroxypropyllignin |
PT668933E (en) * | 1992-11-19 | 2003-02-28 | Anticancer Inc | USE OF METIONINASE AS AN ANTI-TUMOR AGENT IN ANTI-METHIONINE QIMIOTHERAPY |
HU213677B (en) * | 1993-11-09 | 1997-12-29 | Immunal Kft | Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them |
CA2260886A1 (en) * | 1996-07-30 | 1998-02-05 | Novartis Nutrition Ag | Amino acid composition and use thereof in treating tumor growth and metastasis |
EP1068868A3 (en) * | 1997-07-08 | 2001-01-31 | Rath, Matthias, Dr. med. | Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration |
PT1163904E (en) * | 2000-06-16 | 2006-07-31 | Rath Matthias | COMPOSITION FOR THE PREVENTION OF SMOOTH MUSCLE DISEASES, COMPOSING ASCORBATE, ARGININE AND MAGNESIUM |
ATE327747T1 (en) * | 2000-10-09 | 2006-06-15 | Matthias Dr Med Rath | THERAPEUTIC COMBINATION OF ASCORBATE WITH LYSINE AND ARGININE FOR PREVENTION AND TREATMENT OF CANCER |
CH694549A5 (en) | 2001-01-16 | 2005-03-31 | Dr Matthias Rath | A composition comprising an ascorbate and a fibrinolysis inhibitor for treating diseases associated with extracellular matrix degradation e.g. arteriosclerosis, cancer, inflammations and infections |
US6686340B2 (en) | 2001-06-19 | 2004-02-03 | Matthias Rath | Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells |
SG106614A1 (en) * | 2001-06-21 | 2004-10-29 | Matthias Rath Dr | Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body |
WO2003030890A1 (en) * | 2001-10-05 | 2003-04-17 | Tetsuro Asao | Immune system activators |
US20030105104A1 (en) * | 2001-11-27 | 2003-06-05 | Burzynski Stanislaw R. | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
US20050053664A1 (en) | 2003-09-08 | 2005-03-10 | Eliezer Zomer | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
US20070258969A1 (en) * | 2004-03-19 | 2007-11-08 | Eliezer Zomer | Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers |
WO2007016954A1 (en) * | 2005-07-29 | 2007-02-15 | Matuschka-Greiffenclau Markus | Composition for reducing drug or alcohol induced breast cancer risk |
WO2007016949A1 (en) * | 2005-07-29 | 2007-02-15 | Matuschka-Greiffenclau Markus | Composition for reducing the risc of alcohol induced neuropathy |
WO2007016950A1 (en) * | 2005-07-29 | 2007-02-15 | Matuschka-Greiffenclau Markus | Composition for reducing the risk of alcohol induced neurodegenerative disease |
WO2007016952A1 (en) * | 2005-07-29 | 2007-02-15 | Matuschka-Greiffenclau Markus | Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer |
WO2007016951A1 (en) * | 2005-07-29 | 2007-02-15 | Matuschka-Greiffenclau Markus | Composition for reducing the risc of alcohol induced pancreatic cancer |
US8580750B2 (en) | 2005-07-29 | 2013-11-12 | Tima Foundation | Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
WO2007016953A1 (en) * | 2005-07-29 | 2007-02-15 | Matuschka-Greiffenclau Markus | Composition for reducing alcohol induced liver cancer risk |
WO2008119077A1 (en) | 2007-03-28 | 2008-10-02 | University Of Southern California | Induction of differential stress resistance and uses thereof |
US8865646B2 (en) | 2007-03-28 | 2014-10-21 | University Of South California | Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging |
CA2722365C (en) * | 2008-04-24 | 2019-08-06 | University Of Southern California | Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging |
TWI551288B (en) * | 2011-02-17 | 2016-10-01 | Ea Pharma Co Ltd | Antimicrobial activity enhancer for chemotherapeutic agents |
JP2016117702A (en) * | 2014-12-22 | 2016-06-30 | 武輝 山田 | Method for destroying cancer cells |
IT202000000454A1 (en) * | 2020-01-13 | 2021-07-13 | Professional Dietetics Spa | COMPOSITIONS INCLUDING AMINO ACIDS FOR THE PREVENTION AND TREATMENT OF CANCER |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT297935B (en) * | 1968-05-09 | 1972-04-10 | Astra Ab | Process for the preparation of an infusion solution of essential amino acids for intravenous delivery in uremic conditions |
SU423304A3 (en) * | 1970-03-10 | 1974-04-05 | Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани | |
DE2013026C3 (en) * | 1970-03-19 | 1981-01-29 | Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen | Agents for the treatment and prevention of liver diseases and muscular insufficiency |
DE2530246A1 (en) * | 1975-07-07 | 1977-01-13 | Fresenius Chem Pharm Ind | L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE |
DE2531204A1 (en) * | 1975-07-12 | 1977-01-13 | Fresenius Chem Pharm Ind | L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE |
-
1978
- 1978-09-04 JP JP10874978A patent/JPS5535049A/en active Granted
-
1979
- 1979-08-28 GB GB7929789A patent/GB2029220B/en not_active Expired
- 1979-08-29 AU AU50368/79A patent/AU526207B2/en not_active Expired
- 1979-08-31 CA CA334,841A patent/CA1134275A/en not_active Expired
- 1979-09-03 IT IT05216/79A patent/IT1194844B/en active
- 1979-09-03 FR FR7921975A patent/FR2434622A1/en active Granted
- 1979-09-03 SE SE7907316A patent/SE448679B/en not_active IP Right Cessation
- 1979-09-04 NL NLAANVRAGE7906620,A patent/NL190266C/en not_active IP Right Cessation
- 1979-09-04 DE DE2935709A patent/DE2935709C2/en not_active Expired
- 1979-09-04 CH CH799179A patent/CH642541A5/en not_active IP Right Cessation
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10201513B2 (en) | 2016-12-19 | 2019-02-12 | Axcella Health Inc. | Amino acid compositions and methods for the treatment of liver diseases |
US10238617B2 (en) | 2016-12-19 | 2019-03-26 | Axcella Health Inc. | Amino acid compositions and methods for the treatment of liver diseases |
US10471034B2 (en) | 2016-12-19 | 2019-11-12 | Axcella Health Inc. | Amino acid compositions and methods for the treatment of liver diseases |
US11129804B2 (en) | 2016-12-19 | 2021-09-28 | Axcella Health Inc. | Amino acid compositions and methods for the treatment of liver diseases |
US11602511B2 (en) | 2016-12-19 | 2023-03-14 | Axcella Health Inc. | Amino acid compositions and methods for the treatment of liver diseases |
US10660870B2 (en) | 2017-08-14 | 2020-05-26 | Axcella Health Inc. | Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting |
US10682325B2 (en) | 2017-08-14 | 2020-06-16 | Axcella Health Inc. | Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting |
US11571404B2 (en) | 2017-08-14 | 2023-02-07 | Axcella Health Inc. | Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting |
US10596136B2 (en) | 2018-06-20 | 2020-03-24 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
US10973793B2 (en) | 2018-06-20 | 2021-04-13 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
US11833127B2 (en) | 2018-06-20 | 2023-12-05 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
Also Published As
Publication number | Publication date |
---|---|
IT1194844B (en) | 1988-09-28 |
NL190266C (en) | 1994-01-03 |
FR2434622B1 (en) | 1983-04-15 |
GB2029220A (en) | 1980-03-19 |
CA1134275A (en) | 1982-10-26 |
AU5036879A (en) | 1980-03-13 |
FR2434622A1 (en) | 1980-03-28 |
AU526207B2 (en) | 1982-12-23 |
SE7907316L (en) | 1980-03-05 |
DE2935709C2 (en) | 1986-02-06 |
DE2935709A1 (en) | 1980-03-13 |
CH642541A5 (en) | 1984-04-30 |
JPS5535049A (en) | 1980-03-11 |
NL7906620A (en) | 1980-03-06 |
IT7905216A0 (en) | 1979-09-03 |
JPS6154007B2 (en) | 1986-11-20 |
SE448679B (en) | 1987-03-16 |
NL190266B (en) | 1993-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2029220B (en) | Amino acid solutions for patients with cancers | |
EG14182A (en) | Amino acid derivatives as antihypertensives | |
JPS54149294A (en) | Patient transporter | |
ZA79989B (en) | Phenoxyalkylcarboxylic acid derivatives | |
GB2090595B (en) | Threo-3-amino-2-hydroxybutanoylacetice acid derivatives | |
JPS565478A (en) | 22substitutedd66substituteddcarbadethiapenee 22emm33carboxylic acid | |
JPS5692871A (en) | Isoquinolineacetic acid | |
JPS5560269A (en) | Battery connector | |
GB2052484B (en) | Epoxysuccinyl amino acid derivatives | |
GB2117774B (en) | Oximinoacetic acid derivatives | |
GB2022411B (en) | Para-aminobencoic acid derivatives for use in therapy | |
ZA783353B (en) | A-acetylenic amino acid derivatives | |
JPS5668676A (en) | 22aminoo44substituteddthiazolecarboxylic acid | |
GB2001309B (en) | Alpha-halomethyl amino acid derivatives | |
JPS5484544A (en) | Alphaahalomethyl amino acid | |
GB2037283B (en) | -aryloxy-cyclohexylacetic acid derivatives | |
GB2016004B (en) | U-naphthyl-acetic acid derivatives | |
GB2053912B (en) | Acylaminobenzoic acid derivatives | |
GB2026485B (en) | Thiopropanoylamino acid derivatives | |
GB2051781B (en) | Oxoamino acid derivatives | |
GB2125035B (en) | 6b-halopenicillanic acid derivatives | |
JPS54100186A (en) | Vehicle for carrying patient | |
DE3064939D1 (en) | Sulfonylcarboxylic acid derivatives | |
ZA793127B (en) | Novel -amino -phenylacetic acid derivatives | |
IL58886A0 (en) | Vinblastine-23-oyl amino acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE20 | Patent expired after termination of 20 years |
Effective date: 19990827 |